Company Overview and News


Add ATTBF
to your dashboard

Headline News

CFN Media Exclusive CEO Interview: Abattis Validates Lab Strategy, Sets Stage for Rapid Growth

2017-11-06 marketwired
SEATTLE, WA--(Marketwired - Nov 6, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an exclusive executive interview with Rob Abenante, CEO of Abattis Bioceuticals Corp. (CSE: ATT) (CNSX: ATT) (CNSX: ATT.CN) (OTCQB: ATTBF). In the interview, Mr. Abenante discusses the company's cannabis testing and product development strategy in light of the recently announced partnership with Emerald Health Therapeutics. (27-0)

Emerald Health Expands Capabilities with Northern Vine Labs Deal -- CFN Media

2017-11-01 marketwired
SEATTLE, WA--(Marketwired - Nov 1, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering Emerald Health Therapeutics Inc.'s (TSX VENTURE: EMH) (OTCQX: EMHTF) recent deal with Abattis Bioceuticals Corp. to acquire a controlling interest in Northern Vine Labs. The agreement could grow Northern Vine into a thriving center for analytical testing, genetic research and development, tissue culture, and proprietary medicinal and therapeutic formulations. (8-1)

Abattis Offers a Solution to Canada's Cannabis Pesticide Problem -- CFN Media

2017-10-17 marketwired
SEATTLE, WA--(Marketwired - Oct 17, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Abattis Bioceuticals Corp. (CSE: ATT) (CNSX: ATT) (CNSX: ATT.CN) (OTCQB: ATTBF), whose wholly-owned subsidiary is one of the only publicly-traded third-party cannabis testing laboratories. A steady stream of cannabis recalls has prompted regulators in Canada to call for the mandatory testing of cannabis for unauthorized pesticides. (4-0)

Abattis Prepares for Growth in Extracts -- CFN Media

2017-09-20 marketwired
SEATTLE, WA--(Marketwired - Sep 20, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. (CSE: ATT) (ATT.CN) (CNSX: ATT) (OTCQB: ATTBF) and why its proprietary extraction technology represents an important breakthrough that shouldn't be ignored. While many licensed producers are focused on expanding capacity, the best opportunities may be those that can add value for existing licensed producers. (4-0)

It's Easy Being Green

2017-05-16 seekingalpha
Would you have done like everyone else and ignored it? Everyone did. There were no offers. None.

Abattis Announces the Official Launch of Northern Vine Laboratory

2017-05-03 accesswire
VANCOUVER, BC / ACCESSWIRE / May 3, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce that its subsidiary, Northern Vine Canada Inc. ("Northern Vine"), has officially launched its flagship laboratory, having completed its first successful test analysis.

Abattis Signs Exclusive Distribution Agreement for Proprietary Extraction Technology

2017-04-26 accesswire
VANCOUVER, BC / ACCESSWIRE / April 26, 2017 / Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that it has signed an exclusive distribution agreement, effective April 20, 2017 (the "Agreement"), with Suzhou Raybot Material Tech Corp. ("Raybot"). The Agreement allows Abattis to use Raybot's proprietary extraction technology and to exclusively sell the extraction equipment and services.

Abattis Bioceuticals Announces New CEO

2017-04-10 accesswire
VANCOUVER, BC / ACCESSWIRE / April 10, 2017 / Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce the appointment of Robert Abenante as President and Chief Executive Officer of the Company.

Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC

2017-04-06 accesswire
VANCOUVER, BC / ACCESSWIRE / April 6, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), is pleased to announce it has officially been added to The Marijuana Index, within the Biotechnology sector.

Canada's Plans for Near-term Legalization Puts Testing into Focus -- CFN Media

2017-04-04 marketwired
SEATTLE, WA--(Marketwired - Apr 4, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing the planned legalization of cannabis in Canada, the growing and urgent need for testing in both the existing and upcoming legal cannabis markets, and Abattis Bioceuticals Inc.'s (CSE: ATT) (OTCQB: ATTBF) role via the company's federally-licensed subsidiary, Northern Vine Labs.

Abattis: Legislation to Legalize Marijuana in Canada is Being Announced Next Month

2017-03-27 accesswire
VANCOUVER, BC / ACCESSWIRE / March 27, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis"), and its subsidiary, Northern Vine Labs, is anticipating the Liberal government's upcoming announcement, next month (the week of April 10th), on legislation that will legalize recreational marijuana use across Canada by July 1, 2018.

Abattis Welcomes Dr. David Galvez as Science Advisor to Northern Vine

2017-03-20 accesswire
VANCOUVER, BC / ACCESSWIRE / March 20, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce that Dr. David Galvez, PhD, will be joining the team to lead Northern Vine's Science Advisory efforts.

Abattis Team Positions for Next Stage of Growth

2017-03-13 accesswire
VANCOUVER, BC / ACCESSWIRE / March 13, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce the addition of Jaclyn Thomson, PhD, to our senior management team at Northern Vine Labs, and the appointment of Rene David to the Abattis Board of Directors. As the construction and buildout of Northern Vine Labs continues, more key management hires and appointments will accompany this next stage of growth.

CSE: 2017-0301 - Reinstatement - Abattis Bioceuticals Corp. (ATT)

2017-03-03 marketwired
TORONTO, ONTARIO--(Marketwired - March 3, 2017) - Effective immediately the shares of Abattis Bioceuticals Corp. will be reinstated for trading.

Abattis Completes Audit and Prepares to Launch Northern Vine Labs

2017-02-24 accesswire
VANCOUVER, BC / ACCESSWIRE / February 24, 2017 / Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CNSX: ATT) ("ATT" or the "Company") is pleased to announce the completion of their annual audit. The delay in filing was due to an eventful year with new programs coming online and an aggressive strategy to cut non-core assets resulting in prolonged consolidations and subsequent review.

CUSIP: 00258G103